April 20, 2022 FOR IMMEDIATE RELEASE   STATEMENT FROM NCODA LEGISLATIVE & POLICY ADVISORY COMMITTEE Contact: Kevin Scorsone | NCODA Legislative & Policy Liaison Phone: (919) 903-2057 Email: kevin.scorsone@ncoda.org www.ncoda.org WASHINGTON STATE ENDS LEGISLATIVE SESSION WITH WIN FOR PATIENTS The state of Washington wrapped up their legislative session with a huge victory for patients. Senate […]

NCODA and XIFIN Launch New Initiative to Expand Oncology Patient Care Options “NCODA Informatics Initiative Powered by VisualStrata” Helps Attract Clinical Trials for Oncology Practices and Bridges the Gap with Pharmaceutical Organizations San Diego, CA and Cazenovia, NY April 14, 2022 – XIFIN has partnered with NCODA, Inc., a globally recognized association that develops unique […]

FOR IMMEDIATE RELEASE April 6, 2022 STATEMENT FROM NCODA LEGISLATIVE & POLICY ADVISORY COMMITTEE Contact: Kevin Scorsone | NCODA Legislative & Policy Liaison (919) 903-2057 kevin.scorsone@ncoda.org www.ncoda.org OHIO MAKES IT OFFICIAL: UNANIMOUS VICTORY TO BAN COPAY ACCUMULATORS CAZENOVIA, NY – NCODA is proud to share the news that the Ohio House unanimously (86 to 0) […]

FOR IMMEDIATE RELEASE  March 29, 2022 MEDIA CONTACT: Katie Edmiston Katie.Edmiston@NCODA.org 813-843-1629   NCODA Now Certified To Provide Continuing Education For Pharmacists & Pharmacy Technicians   CAZENOVIA, NY – NCODA, a professional association dedicated to empowering the medically-integrated oncology community through leadership, quality standards, and best practices, is now certified by the Accreditation Council for […]

The challenges associated with medication adherence and the negative impacts of non-adherence have been well documented. Medication adherence affects many aspects of public health, including, but not limited to, quality of life, patient outcomes, and overall healthcare costs.1 It is generally accepted that adherence rates of more than 80% are needed for optimal therapeutic efficacy.2 […]

The development and utilization of oral oncolytics has steadily increased over the past 20 years. There are over 800 new oncology therapies in the drug development pipeline, 25%-35% of which are oral agents.1 The use of oral oncolytics presents unique challenges to patient safety compared to intravenous cancer treatments. As oral oncolytics are self-administered, it […]

FOR IMMEDIATE RELEASE March 15, 2022 MEDIA CONTACT: Stephen Ziter Stephen.Ziter@ncoda.com 518-867-5001   First-Of-Its-Kind Oncology State Legislation Tracking Tool NCODA Launches a New Comprehensive Resource to Allow Oncology Healthcare Professionals to Stay Updated on the Latest in Relevant Policy/Legislation in all 50 States CAZENOVIA, NY – Today, NCODA announces the launch of its new and […]

– VONJO is the First Approved Therapy to Specifically Address the Needs of Adult Cytopenic Myelofibrosis Patients – NDA Approved Under Priority Review – Approval Triggers $60 Million Payment from DRI Healthcare Trust – CTI to Host Conference Call Tomorrow at 8:00 a.m. ET SEATTLE, Feb. 28, 2022 /PRNewswire/ — CTI BioPharma Corp. (Nasdaq: CTIC) today announced the U.S. […]

FOR IMMEDIATE RELEASE   STATEMENT FROM NCODA LEGISLATIVE & POLICY ADVISORY COMMITTEE Contact: Kevin Scorsone | NCODA Legislative & Policy Liaison (919) 903-2057 kevin.scorsone@ncoda.org www.ncoda.org Federal Trade Commission Seeking Information on How PBMs Impact Practices and Patients On February 24, 2022, the Federal Trade Commission (FTC) announced that they are soliciting public input on the […]

FOR IMMEDIATE RELEASE STATEMENT FROM NCODA’S LEGISLATIVE & POLICY ADVISORY COMMITTEE Contact: Kevin Scorsone | NCODA Legislative & Policy Liaison Phone: (919) 903-2057 Email: kevin.scorsone@ncoda.org www.ncoda.org PBM REFORM BILL MAKING STRIDES IN VIRGINIA HOUSE OF REPRESENTATIVES          In recent weeks, NCODA has been closely following and applauding PBM reform along with new provisions regarding patient copayments. […]

February 18, 2022   FOR IMMEDIATE RELEASE   STATEMENT FROM NCODA LEGISLATIVE & POLICY ADVISORY COMMITTEE Contact: Kevin Scorsone | NCODA Legislative & Policy Liaison Phone: (919) 903-2057 Email: kevin.scorsone@ncoda.org www.ncoda.org OVERWHELMING CONSENSUS IN HOUSE PUTS PBM BILL ON DOORSTEP A Comprehensive PBM Reform Bill is on the Desk of Michigan Gov. Gretchen Whitmer Awaiting […]